[1]
2021. EVALUATING CLINICAL OUTCOMES OVER LONG TERM RESULTS FOR BONE AND SOFT-TISSUE SARCOMAS . International Research Journal of Pharmacy. 12, 11 (Nov. 2021), 21–24.